A Non-canonical Pathway with Potential for Safer Modulation of Transforming Growth Factor-beta 1 in Steroid-Resistant Airway Diseases
Meina Li, Christine R Keenan, Guillermo Lopez-Campos, Jonathan E Mangum, Qianyu Chen, Danica Prodanovic, Yuxiu C Xia, Shenna Y Langenbach, Trudi Harris, Vinzenz Hofferek, Gavin E Reid, Alastair G Stewart
iScience | CELL PRESS | Published : 2019
Related Projects (2)
Awarded by NHMRC
We thank the expert assistance from the Center for Translational Pathology, The University of Melbourne, for RNA-seq in this study, and Mass Spectrometry and Proteomics Platform, Bio21 Institute's Research Facility, The University of Melbourne, for proteomic analysis in this study. We also acknowledge Associate Professor Vera Ignjatovic for assistance in analyzing proteomic results. We thank the research and clinical investigators of the MESCA group, including C.F. Robertson (Royal Children's Hospital Melbourne), J. Wilson (Monash University), D. Smallwood, E. Horak, and M. Roberts (Royal Children's Hospital Melbourne). This work was funded by grants from Asthma Australia; NHMRC (1059665, 1137171) and Victorian Medical Research Acceleration Fund.